CN1763021A - 一种提纯奥利司他的方法 - Google Patents
一种提纯奥利司他的方法 Download PDFInfo
- Publication number
- CN1763021A CN1763021A CN 200510094601 CN200510094601A CN1763021A CN 1763021 A CN1763021 A CN 1763021A CN 200510094601 CN200510094601 CN 200510094601 CN 200510094601 A CN200510094601 A CN 200510094601A CN 1763021 A CN1763021 A CN 1763021A
- Authority
- CN
- China
- Prior art keywords
- orlistat
- solvent
- sample
- purifying
- crystallization
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 title claims abstract description 70
- 229960001243 orlistat Drugs 0.000 title claims abstract description 70
- 238000000034 method Methods 0.000 title claims abstract description 28
- 238000002425 crystallisation Methods 0.000 claims abstract description 29
- 230000008025 crystallization Effects 0.000 claims abstract description 28
- 239000002904 solvent Substances 0.000 claims abstract description 24
- 239000012454 non-polar solvent Substances 0.000 claims abstract description 12
- 238000001953 recrystallisation Methods 0.000 claims abstract description 4
- 238000001914 filtration Methods 0.000 claims abstract description 3
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical group CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 32
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 24
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 21
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 11
- 239000000706 filtrate Substances 0.000 claims description 4
- 239000012535 impurity Substances 0.000 abstract description 18
- 238000000746 purification Methods 0.000 abstract description 13
- 238000009776 industrial production Methods 0.000 abstract description 2
- SIKWOTFNWURSAY-UHFFFAOYSA-N Lipstatin Natural products CCCCCCC1C(CC(CC=CCC=CCCCCC)C(=O)OC(CC(C)C)NC=O)OC1=O SIKWOTFNWURSAY-UHFFFAOYSA-N 0.000 description 13
- OQMAKWGYQLJJIA-CUOOPAIESA-N lipstatin Chemical compound CCCCCC[C@H]1[C@H](C[C@H](C\C=C/C\C=C/CCCCC)OC(=O)[C@H](CC(C)C)NC=O)OC1=O OQMAKWGYQLJJIA-CUOOPAIESA-N 0.000 description 13
- 239000000356 contaminant Substances 0.000 description 11
- 238000004519 manufacturing process Methods 0.000 description 11
- 238000005984 hydrogenation reaction Methods 0.000 description 10
- 239000000047 product Substances 0.000 description 9
- 238000000855 fermentation Methods 0.000 description 7
- 230000004151 fermentation Effects 0.000 description 7
- 238000004128 high performance liquid chromatography Methods 0.000 description 7
- 238000000605 extraction Methods 0.000 description 5
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 4
- 230000002950 deficient Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 241000187747 Streptomyces Species 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000010606 normalization Methods 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000000967 suction filtration Methods 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 229940086609 Lipase inhibitor Drugs 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 150000002613 leucine derivatives Chemical class 0.000 description 1
- 229960004232 linoleic acid Drugs 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2005100946014A CN1763021B (zh) | 2005-09-29 | 2005-09-29 | 一种提纯奥利司他的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2005100946014A CN1763021B (zh) | 2005-09-29 | 2005-09-29 | 一种提纯奥利司他的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1763021A true CN1763021A (zh) | 2006-04-26 |
CN1763021B CN1763021B (zh) | 2010-08-11 |
Family
ID=36747369
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2005100946014A Active CN1763021B (zh) | 2005-09-29 | 2005-09-29 | 一种提纯奥利司他的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1763021B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102070567A (zh) * | 2011-01-21 | 2011-05-25 | 天津市海德安科医药科技发展有限公司 | 反相高效液相色谱制备高纯度奥利司他的方法 |
CN102070568A (zh) * | 2011-02-28 | 2011-05-25 | 珠海联邦制药股份有限公司 | 一种奥利司他的制备方法 |
CN102558103A (zh) * | 2010-12-13 | 2012-07-11 | 山东新时代药业有限公司 | 一种分离和纯化奥利司他的方法 |
CN102993135A (zh) * | 2012-12-31 | 2013-03-27 | 山东新时代药业有限公司 | 一种奥利司他的纯化方法 |
CN103739572A (zh) * | 2014-01-09 | 2014-04-23 | 山东新时代药业有限公司 | 一种奥利司他结晶母液回收工艺 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2185523T3 (es) * | 1999-01-29 | 2003-05-01 | Hoffmann La Roche | Purificacion de lipstatina. |
IL162323A0 (en) * | 2001-12-04 | 2005-11-20 | Biogal Pharmaceutical Co | Preparation of orlistat and orlistat crystalline forms |
WO2005007639A1 (en) * | 2003-07-17 | 2005-01-27 | Biocon Limited | Preparation of tetrahydrolipstatin by hydrogenation of lipstatin, solvent extraction and purification |
PT1673359E (pt) * | 2003-09-12 | 2009-10-06 | Ranbaxy Lab Ltd | Processo para a preparação de formas cristalinas de orlistat |
-
2005
- 2005-09-29 CN CN2005100946014A patent/CN1763021B/zh active Active
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102558103A (zh) * | 2010-12-13 | 2012-07-11 | 山东新时代药业有限公司 | 一种分离和纯化奥利司他的方法 |
CN102558103B (zh) * | 2010-12-13 | 2015-01-14 | 山东新时代药业有限公司 | 一种分离和纯化奥利司他的方法 |
CN102070567A (zh) * | 2011-01-21 | 2011-05-25 | 天津市海德安科医药科技发展有限公司 | 反相高效液相色谱制备高纯度奥利司他的方法 |
CN102070568A (zh) * | 2011-02-28 | 2011-05-25 | 珠海联邦制药股份有限公司 | 一种奥利司他的制备方法 |
WO2012116520A1 (zh) * | 2011-02-28 | 2012-09-07 | 珠海联邦制药股份有限公司 | 一种奥利司他的制备方法 |
CN102070568B (zh) * | 2011-02-28 | 2012-09-26 | 珠海联邦制药股份有限公司 | 一种奥利司他的制备方法 |
CN102993135A (zh) * | 2012-12-31 | 2013-03-27 | 山东新时代药业有限公司 | 一种奥利司他的纯化方法 |
CN102993135B (zh) * | 2012-12-31 | 2015-09-09 | 山东新时代药业有限公司 | 一种奥利司他的纯化方法 |
CN103739572A (zh) * | 2014-01-09 | 2014-04-23 | 山东新时代药业有限公司 | 一种奥利司他结晶母液回收工艺 |
CN103739572B (zh) * | 2014-01-09 | 2016-01-27 | 山东新时代药业有限公司 | 一种奥利司他结晶母液回收工艺 |
Also Published As
Publication number | Publication date |
---|---|
CN1763021B (zh) | 2010-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1763021B (zh) | 一种提纯奥利司他的方法 | |
CN1824669A (zh) | 一种阿维菌素Bla的结晶方法 | |
CN101041658A (zh) | 2-杂环取代的二氢嘧啶消旋化合物的拆分方法 | |
KR100582620B1 (ko) | 고순도의 HMG-CoA 환원효소 억제제 획득방법 | |
RU2303040C2 (ru) | Очистка пептидов | |
CN104844620A (zh) | 一种雷帕霉素的分离纯化方法 | |
CA2640401C (en) | Process for the isolation of calliterpenone (16alpha, 17-dihydroxy-3-oxo-phyllocladane) | |
CN101531629B (zh) | 由消旋的马来酸氨氯地平制备左旋氨氯地平的方法 | |
CN1290853C (zh) | 默诺霉素的纯化方法 | |
RU2260582C2 (ru) | Способ очистки правастатина | |
CN1166634C (zh) | 15n-l-脯氨酸的分离提纯方法 | |
CN102617327B (zh) | 右旋布洛芬化合物及其制法 | |
CN102321040B (zh) | 一种制备利奈唑胺中间体及利奈唑胺的方法 | |
CN114853593A (zh) | 一种从元宝枫油中提取高纯神经酸的方法 | |
CN1611936A (zh) | 模拟移动床色谱分离提纯银杏内酯b的方法 | |
EP1670767B2 (en) | Resolution of a narwedine amide derivative | |
CN1286816C (zh) | 从莲子心中分离制备莲心碱、异莲心碱和甲基莲心碱的方法 | |
CN1164853A (zh) | (s)-n,n'-二[2-羟基-1-(羟甲基)乙基)-5-[(2-羟基-1-氧代丙基)氨基]-2,4,6-三碘-13-苯二羧酰胺从水中结晶的方法 | |
CN1226278C (zh) | 盐酸去甲金霉素结晶母液的回收方法 | |
CN1312814A (zh) | 制备棒酸盐类及其酯类的改进方法 | |
JP2012506877A (ja) | エリスロマイシンの結晶化方法 | |
CN112390715A (zh) | 一种从银杏叶提取物吸附下柱水中提取莽草酸与奎宁酸的方法 | |
CN1442407A (zh) | 光学纯的非索非那定及其盐酸盐的化学拆分制备法 | |
CN102993145B (zh) | 一种提取纯化洛伐他汀的方法 | |
CN103880798A (zh) | 一种纯化霉酚酸的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: NEW DRUG RESEARCH INSTITUTE CO., LTD. OF HANGZHOU Free format text: FORMER NAME: BIOENGINEERING INST. CO., LTD., HANGZHOU EAST-CHINA MEDICINE GROUP |
|
CP01 | Change in the name or title of a patent holder |
Address after: Hangzhou City, Zhejiang province 310011 Moganshan Road No. 866 Patentee after: HANGZHOU HUADONG MEDICINE GROUP NEW MEDICINE RESEARCH INSTITUTE CO., LTD. Address before: Hangzhou City, Zhejiang province 310011 Moganshan Road No. 866 Patentee before: Hangzhou Huadong Medicine Group Biological Engineering Research Institute Co., Ltd. |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20060426 Assignee: Hangzhou Huadi Pharmaceutical Technology Co.,Ltd. Assignor: Hangzhou Huadong Medicine Group Biopharmaceutical Co.,Ltd. Contract record no.: X2021330000100 Denomination of invention: A method for purifying orlistat Granted publication date: 20100811 License type: Common License Record date: 20210820 |